AVG-233

• CAT Number: I042960
• CAS Number: 2151937-80-1
• Molecular Formula: C26H22ClN5O3
• Molecular Weight: 487.94
• Purity: ≥95%
• Synonyms: 5-[(6-chloropyridin-2-yl)methyl]-1-[(4-methoxyphenyl)methyl]-4-methyl-2-pyridin-2-ylpyrazolo[4,3-c]pyridine-3,6-dione
• InChI: InChI=1S/C26H22ClN5O3/c1-17-25-21(14-24(33)30(17)16-19-6-5-7-22(27)29-19)31(15-18-9-11-20(35-2)12-10-18)32(26(25)34)23-8-3-4-13-28-23/h3-14H,15-16H2,1-2H3
• InChIKey: CXZZYJLIYWCICH-UHFFFAOYSA-N
• SMILES: CC1=C2C(=CC(=O)N1CC3=NC(=CC=C3)Cl)N(N(C2=O)C4=CC=CC=N4)CC5=CC=C(C=C5)OC

AVG-233（Cat No.:I042960）is an investigational compound being studied for its potential use in cancer therapy. It is designed to target and inhibit specific signaling pathways involved in tumor growth, survival, and metastasis. AVG-233 works by disrupting the activity of key molecules that contribute to cancer cell proliferation and resistance to apoptosis. Preclinical studies have shown promising results, suggesting that AVG-233 can reduce tumor growth and enhance the effects of other cancer therapies. Ongoing research is focused on evaluating its safety, efficacy, and potential in clinical trials for various cancer types.